Vulnerable Populations Flashcards

1
Q

How often should patients on feminizing hormones be monitored?

A

Baseline, three months, six months, and yearly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are some possible contraindications to estrogen therapy?

A

Unstable ischemic CVD disease, estrogen dependent cancers, end stage chronic liver disease, psychiatric conditions that limit ability to provide informed consent, hypersensitivity/allergy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When should discontinuation of hormone therapy be considered?

A

Fertility preservation, pregnancy, surgery, old age, health issues, financial, need to change gender presentation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

For a 23 year old female newly arriving from the Caribbean, what vaccinations should be provided?

A

HPV, DPT, varicella, MMR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are some reversible changes of feminizing hormone therapy?

A

Reduction in muscle mass, reduction of body/facial hair, changes to skin/sweat, changes to body fat distribution, changes to libido

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are some irreversible changes with feminizing hormone therapy?

A

Reduced testicular and prostatic size, sperm count reduction, breast development

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the two anti-androgens used with feminizing therapy and what are the typical doses?

A

Spironolactone 50 mg daily-BID (usual dose 100 mg BID, max 150 mg) and cyproterone 12.5 mg q2d-daily (usual 25 mg daily, max 50 mg)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What routes of administration can occur with feminizing hormone therapy?

A

Oral anti-androgen, oral or transdermal (gel/patch) estrogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the typical dose of oral estrogen for feminizing hormone therapy?

A

1-2 mg daily with usual dose of 4mg daily or 2 mg BID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are some limitations of estrogen for feminizing hormone therapy?

A

Does not affect the pitch of the voice, does not eliminate facial or neck hair, does not have significant impact on breast growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are some reversible changes of masculinizing hormone therapy?

A

Fat redistribution, increased muscle mass, cessation of menses, hair growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are some irreversible changes of masculinizing hormone therapy?

A

Clitoral growth, voice changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When is the cessation of menses generally achieved with masculinizing therapy?

A

Within 3-6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the route of administration of testosterone and the usual dose?

A

Injection 20-50 mg IM/SC weekly (max 100 mg) or transdermal (patch or gel)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are contraindications to testosterone therapy?

A

Pregnancy/breastfeeding, active/known hormone-sensitive cancer, unstable CVD disease, poorly controlled psychosis, psychiatric conditions that limit ability to provide informed consent, hypersensitivity/allergy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly